Winton Group’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,480
| Closed | -$23K | – | 1347 |
|
|
2021
Q2 | $23K | Sell |
1,480
-566
| -28% | -$8.8K | ﹤0.01% | 1406 |
|
|
2021
Q1 | $49K | Buy |
2,046
+66
| +3% | +$1.58K | ﹤0.01% | 1352 |
|
|
2020
Q4 | $58K | Sell |
1,980
-5,703
| -74% | -$167K | ﹤0.01% | 1283 |
|
|
2020
Q3 | $118K | Sell |
7,683
-2,623
| -25% | -$40.3K | ﹤0.01% | 1389 |
|
|
2020
Q2 | $258K | Buy |
10,306
+1,753
| +20% | +$43.9K | 0.01% | 1314 |
|
|
2020
Q1 | $174K | Buy |
8,553
+2,678
| +46% | +$54.5K | ﹤0.01% | 1272 |
|
|
2019
Q4 | $182K | Buy |
5,875
+534
| +10% | +$16.5K | ﹤0.01% | 1449 |
|
|
2019
Q3 | $178K | Buy |
+5,341
| New | +$178K | ﹤0.01% | 1409 |
|
|
2019
Q2 | – | Sell |
-5,046
| Closed | -$145K | – | 1138 |
|
|
2019
Q1 | $145K | Buy |
+5,046
| New | +$145K | ﹤0.01% | 1001 |
|